Abstract
Despite considerable efforts from multiple laboratories worldwide, highly specific inhibitors of autophagy for clinical use are not yet available. Lysosomal inhibitors are being employed instead, in spite of multiple limitations that are summarized herein.
| Original language | English |
|---|---|
| Pages (from-to) | 112168-112169 |
| Number of pages | 2 |
| Journal | Oncotarget |
| Volume | 8 |
| Issue number | 68 |
| DOIs | |
| State | Published - 2017 |
| Externally published | Yes |
Keywords
- Anticancer immunosurveillance
- Autophagy
- Chemotherapy
- Chloroquine
- Hydroxychloroquine
